Effects of menopause on brain structural changes in schizophrenia

Psychiatry and Clinical Neurosciences

Volumn 67, Issue 1, 2013, Pages 3-11

  Fukuta, Hajime ^a   Ito, Itsuo ^a   Tateno, Amane ^a   Nogami, Tsuyoshi ^a   Taiji, Yasutomo ^b   Arakawa, Ryosuke ^c   Suhara, Tetsuya ^c   Asai, Kunihiko ^b   Okubo, Yoshiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Asai Hospital   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

brain morphology; estrogen; female; menopause; schizophrenia

Indexed keywords

ADULT; ANTERIOR CINGULATE; ARTICLE; BRAIN; BRAIN SIZE; CATATONIC SCHIZOPHRENIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; GRAY MATTER; HEBEPHRENIA; HUMAN; INSULA; MIDDLE FRONTAL GYRUS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARAHIPPOCAMPAL GYRUS; PARANOID SCHIZOPHRENIA; POSTMENOPAUSE; PREMENOPAUSE; RESIDUAL SCHIZOPHRENIA; SUPERIOR FRONTAL GYRUS; SUPERIOR TEMPORAL GYRUS; SYMPTOM; THALAMUS; VOXEL BASED MORPHOMETRY;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN MAPPING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MENOPAUSE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 84872708809     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12003     Document Type: Article

References (39)

1. Seeman MV,. Interaction of sex, age, and neuroleptic dose. Compr. Psychiatry 1983; 24: 125-128.
2. Bardenstein KK, McGlashan TH,. Gender differences in affective, schizoaffective, and schizophrenic disorders. A review. Schizophr. Res. 1990; 3: 159-172.
3. Hafner H, Riecher A, Maurer K, Loffler W, Munk-Jorgensen P, Stromgren E,. How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol. Med. 1989; 19: 903-918.
4. Castle DJ, Murray RM,. The epidemiology of late-onset schizophrenia. Schizophr. Bull. 1993; 19: 691-700.
5. Grigoriadis S, Seeman MV,. The role of estrogen in schizophrenia: Implications for schizophrenia practice guidelines for women. Can. J. Psychiatry 2002; 47: 437-442.
6. Nopoulos P, Flaum M, Andreasen NC,. Sex differences in brain morphology in schizophrenia. Am. J. Psychiatry 1997; 154: 1648-1654.
7. Gur RE, Turetsky BI, Cowell PE, et al. Temporolimbic volume reductions in schizophrenia. Arch. Gen. Psychiatry 2000; 57: 769-775.
8. Job DE, Whalley HC, McConnell S, Glabus M, Johnstone EC, Lawrie SM,. Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. Neuroimage 2002; 17: 880-889.
9. Suzuki M, Nohara S, Hagino H, et al. Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophr. Res. 2002; 55: 41-54.
10. Bryant NL, Buchanan RW, Vladar K, Breier A, Rothman M,. Gender differences in temporal lobe structures of patients with schizophrenia: A volumetric MRI study. Am. J. Psychiatry 1999; 156: 603-609.
11. Boccardi M, Ghidoni R, Govoni S, et al. Effects of hormone therapy on brain morphology of healthy postmenopausal women: A voxel-based morphometry study. Menopause 2006; 13: 584-591.
12. Lord C, Buss C, Lupien SJ, Pruessner JC,. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: A possible window of opportunity effect. Neurobiol. Aging 2008; 29: 95-101.
13. Robertson D, Craig M, van, Amelsvoort T, et al. Effects of estrogen therapy on age-related differences in gray matter concentration. Climacteric 2009; 12: 301-309.
14. Ashburner J, Friston KJ,. Voxel-based morphometry: The methods. Neuroimage 2000; 11: 805-821.
15. Koutsouleris N, Gaser C, Jager M, et al. Structural correlates of psychopathological symptom dimensions in schizophrenia: A voxel-based morphometric study. Neuroimage 2008; 39: 1600-1612.
16. Premkumar P, Fannon D, Kuipers E, Cooke MA, Simmons A, Kumari V,. Association between a longer duration of illness, age and lower frontal lobe grey matter volume in schizophrenia. Behav. Brain Res. 2008; 193: 132-139.
17. McClure RK, Phillips I, Jazayerli R, Barnett A, Coppola R, Weinberger DR,. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment. Psychiatry Res. 2006; 148: 121-132.
18. Treloar AE,. Menarche, menopause, and intervening fecundability. Hum. Biol. 1974; 46: 89-107.
19. Overall JE, Brown WL,. A factor analysis of several measures of choice behavior from a probability learning situation. J. Gen. Psychol. 1962; 66: 115-128.
20. Faustmann PM, Ganz RE,. Central cardio-autonomic disorganization in interictal states of epilepsy detected by phase space analysis. Int. J. Neurosci. 1994; 78: 43-47.
21. Thiemann S, Csernansky JG, Berger PA,. Rating scales in research: The case of negative symptoms. Psychiatry Res. 1987; 20: 47-55.
22. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS,. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 21-36.
23. Friston KJ, Tononi G, Reeke GN Jr, Sporns O, Edelman GM,. Value-dependent selection in the brain: Simulation in a synthetic neural model. Neuroscience 1994; 59: 229-243.
24. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS,. The relationship between global and local changes in PET scans. J. Cereb. Blood Flow Metab. 1990; 10: 458-466.
25. Brett M, Johnsrude IS, Owen AM,. The problem of functional localization in the human brain. Nat. Rev. Neurosci. 2002; 3: 243-249.
26. Rey M, Dellatolas G, Bancaud J, Talairach J,. Hemispheric lateralization of motor and speech functions after early brain lesion: Study of 73 epileptic patients with intracarotid amytal test. Neuropsychologia 1988; 26: 167-172.
27. Lancaster JL, Woldorff MG, Parsons LM, et al. Automated Talairach atlas labels for functional brain mapping. Hum. Brain Mapp. 2000; 10: 120-131.
28. Glahn DC, Laird AR, Ellison-Wright I, et al. Meta-analysis of gray matter anomalies in schizophrenia: Application of anatomic likelihood estimation and network analysis. Biol. Psychiatry 2008; 64: 774-781.
29. Honea R, Crow TJ, Passingham D, Mackay CE,. Regional deficits in brain volume in schizophrenia: A meta-analysis of voxel-based morphometry studies. Am. J. Psychiatry 2005; 162: 2233-2245.
30. Goldman-Rakic PS, Selemon LD,. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr. Bull. 1997; 23: 437-458.
31. Boldsen JL, Jeune B,. Distribution of age at menopause in two Danish samples. Hum. Biol. 1990; 62: 291-300.
32. McKinlay SM, Bifano NL, McKinlay JB,. Smoking and age at menopause in women. Ann. Intern. Med. 1985; 103: 350-356.
33. Brambilla DJ, McKinlay SM,. A prospective study of factors affecting age at menopause. J. Clin. Epidemiol. 1989; 42: 1031-1039.
34. Tamada T, Iwasaki H,. [Age at natural menopause in Japanese women.] Nihon. Sanka Fujinka Gakkai Zasshi 1995; 47: 947-952.
35. Smith S, Wheeler MJ, Murray R, O'Keane V,. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis. J. Clin. Psychopharmacol. 2002; 22: 109-114.
36. Al-Azzawi F, Palacios S,. Hormonal changes during menopause. Maturitas 2009; 63: 135-137.
37. Hafner H, der Heiden W, Hambrecht M, et al. [A chapter in systematic schizophrenia research: The search for causal explanations for sex differences in age of onset.] Nervenarzt 1993; 64: 706-716.
38. Resnick SM, Espeland MA, Jaramillo SA, et al. Postmenopausal hormone therapy and regional brain volumes: The WHIMS-MRI Study. Neurology 2009; 72: 135-142.
39. Greenberg DL, Payne ME, MacFall JR, Provenzale JM, Steffens DC, Krishnan RR,. Differences in brain volumes among males and female hormone-therapy users and nonusers. Psychiatry Res. 2006; 147: 127-134.